×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Kwality Pharmaceuticals Limite | NA | NA | NA | NA | 982.0 | 22.6 |
| Bharat Parenterals Limited | NA | NA | NA | NA | 941 | 38.8 |
| NGL FINE-CHEM LTD. | 1074.12 | 76.44 | 1008.58 | 12.37 | 929 | 44.6 |
Kwality Pharmaceuticals Limited, with Security Code 539997, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 56.0 | 68.8 | 67.5 | 69.7 | 78.1 | 92.0 | 80.1 | 90.0 | 84.4 | 115.7 |
| Expenses | 40.8 | 57.3 | 53.6 | 54.4 | 61.4 | 71.1 | 62.7 | 70.4 | 66.9 | 89.7 |
| Operating Profit | 15.2 | 11.5 | 13.8 | 15.3 | 16.7 | 20.9 | 17.4 | 19.7 | 17.5 | 25.9 |
| OPM % | 27.09% | 16.74% | 20.47% | 21.92% | 21.39% | 22.68% | 21.68% | 21.86% | 20.74% | 22.43% |
| Other Income | 0.4 | -15.1 | 0.4 | 0.2 | 0.6 | -6.5 | 0.3 | 0.2 | 0.7 | 0.8 |
| Interest | 2.0 | 1.7 | 2.2 | 2.4 | 2.7 | 3.1 | 2.5 | 2.7 | 2.2 | 2.5 |
| Depreciation | 3.5 | 4.4 | 4.8 | 4.9 | 4.8 | 5.0 | 4.0 | 4.6 | 4.5 | 5.1 |
| Profit before tax | 10.0 | 6.9 | 7.2 | 8.2 | 9.8 | 13.3 | 11.1 | 12.6 | 11.4 | 19.1 |
| Tax % | -28% | -23.7% | -24.8% | -23.8% | -21.2% | -28% | -24.9% | -32.6% | -25.2% | -23.6% |
| Net Profit | 7.2 | -7.4 | 5.4 | 6.3 | 7.7 | 4.5 | 8.4 | 8.5 | 8.5 | 14.5 |
| EPS in Rs | 6.92 | -7.15 | 5.17 | 6.03 | 7.42 | 4.33 | 8.06 | 8.18 | 8.23 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 56.2 | 68.8 | 67.5 | 69.7 | 78.1 | 92.0 | 80.1 | 90.0 | 84.4 | 115.7 |
| Expenses | 41.1 | 57.3 | 53.7 | 54.4 | 61.4 | 71.4 | 62.7 | 70.4 | 66.9 | 89.7 |
| Operating Profit | 15.1 | 11.5 | 13.8 | 15.2 | 16.7 | 20.6 | 17.3 | 19.7 | 17.5 | 26.0 |
| OPM % | 26.87% | 16.69% | 20.42% | 21.87% | 21.37% | 22.42% | 21.66% | 21.84% | 20.73% | 22.44% |
| Other Income | 0.4 | -15.1 | 0.4 | 0.2 | 0.6 | -6.5 | 0.3 | 0.2 | 0.7 | 0.8 |
| Interest | 2.0 | 1.7 | 2.2 | 2.4 | 2.7 | 3.1 | 2.5 | 2.7 | 2.2 | 2.5 |
| Depreciation | 3.6 | 4.4 | 4.8 | 4.9 | 4.8 | 5.1 | 4.0 | 4.6 | 4.6 | 5.1 |
| Profit before tax | 9.9 | 6.8 | 7.2 | 8.2 | 9.8 | 13.1 | 11.1 | 12.6 | 11.4 | 19.1 |
| Tax % | -28.2% | -23.5% | -24.9% | -23.9% | -21.3% | -29.2% | -24.9% | -32.6% | -25.2% | -23.6% |
| Net Profit | 7.1 | -7.4 | 5.4 | 6.2 | 7.7 | 4.2 | 8.3 | 8.5 | 8.5 | 14.5 |
| EPS in Rs | 6.82 | -7.23 | 5.1 | 5.99 | 7.39 | 4.08 | 8.04 | 8.15 | 8.21 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 22% |
| 3 Years: | -7% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 37% |
| 3 Years: | -31% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 92% |
| 3 Years: | 31% |
| 1 Year: | 86% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 22% |
| 3 Years: | -7% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | 37% |
| 3 Years: | -31% |
| TTM: | 38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 92% |
| 3 Years: | 31% |
| 1 Year: | 86% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|